Jeffrey Holzbeierlein, MD - physician-in-chief of The University of Kansas Cancer Center - joins Dr. Roy Jensen in the podcast studio this week to discuss the future of cancer care and research in our region. Dr. Holzbeierlein is the William L. Valk endowed professor and chair of the Department of Urology at the University of Kansas Medical Center. He specializes in urologic cancer surgery, especially bladder, kidney, penile and testicular cancer. His research interests include Hsp90 inhibitors in bladder cancer and improving cystectomy (bladder removal) outcomes. Do you have questions about cancer? Call our Bench to Bedside Hotline at (913) 588-3880 or email us at benchtobedside@kumc.edu, and your comment or question may be shared on an upcoming episode!
